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Dear Sir: 
 
Recessive mutations in the SLC29A3 gene have 
recently been shown to result in diabetes [1, 2]. In the 
last year eleven families with the H syndrome 
(OMIM#612391) and five families with pigmented 
hypertrichosis with insulin dependent diabetes (PHID) 
have been described, resulting from seven different 
recessive SLC29A3 mutations. The most common 
feature in all but two cases is pigmented hypertrichosis. 
Hyperglycaemia is an overlapping feature of the two 
syndromes although it is much rarer in the H syndrome 
where it is present in 1/15 subjects [1, 3] compared to 
5/6 subjects with PHID [2, 4, 5]. The median age of 
diagnosis for diabetes was 12 years (range: 4-15 years), 
all patients were insulin treated with only 1/5 testing 
positive for GAD autoantibodies. It is not known if 
milder mutations in the SLC29A3 gene can cause 
autoantibody negative type 1 diabetes without 
associated syndromic features. 
The SLC29A3 gene encodes ENT3, a member of the 
equilibrative nucleoside transporter family (SLC29), 
which mediates intracellular trafficking of nucleosides 
[6]. In man the SLC29A3 gene is most highly expressed 
in uterus [7]. In vivo studies of the Drosophila 
melanogatser ortholog of SLC29A3 (ENT1) have 
shown it interacts the insulin signalling pathway, 
although the molecular basis of the interaction has yet 
to be characterised [2]. In addition, it has been detected 
in total human pancreas but it is not known if it is 
expressed in the exocrine component or in the islets 
[7]. 
In order to determine whether the SLC29A3 gene is 
expressed in endocrine pancreas, we quantified 
SLC29A3 transcripts by real-time PCR in human islet, 
pancreas and uterine RNA, relative to that of the 
HNF4A gene, which has documented expression in the 
beta cell [8]. B2M was used as an endogenous control. 
Probes to SLC29A3 mRNA were targeted to the exon 
5-6 junction of the SLC29A3 gene (NM_018344.4) and 
were validated by standard curve analysis over eight 
1.10 serial dilutions (r2 0.99). The expression levels of 
B2M, HNF4A and SLC29A3 transcripts were calculated 
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from average crossing points of triplicate samples, 
using the comparative Ct (ΔΔCt) method [9]. 
Compared to uterine SLC29A3 mRNA levels there 
were 17% and 2% expression in the pancreas and islets 
respectively (relative to B2M). Moreover SLC29A3 
mRNA makes up only a small proportion of the beta 
cell transcriptome representing 0.4% of transcripts 
detected for HNF4A. Therefore SLC29A3 is detectable 
in both exocrine and endocrine pancreas, although the 
expression is lower in the latter. 
Early-onset diabetes is a feature of both the H 
syndrome and PHID. We hypothesised that mutations 
in the SLC29A3 gene could cause isolated diabetes in 
children and screened 47 cases diagnosed at a median 
of 5 years (range: 1-16 years) with autoantibody 
negative type 1 diabetes (antibodies tested at or soon 
after diagnosis; glutamic acid decarboxylase and/or 
islet antigen 2), and without pigmented hypertrichosis. 
Mutations in the HNF1A, HNF4A, KCNJ11 and INS 
genes were excluded by sequence analysis in all 
subjects. 
We amplified the 6 exons of SLC29A3 (primer 
sequences available on request), including the 
exon/intron boundaries and non-coding exon 1. We did 
not identify any pathogenic SLC29A3 mutations, but 
the common non-synonymous polymorphisms 
rs2277257, rs780668, rs2252996, and rs2487068 were 
present at a minor allele frequency of 71%, 7%, 9% 
and 6%, respectively. 
We have shown that SLC29A3 is expressed in the 
human islet and recessive mutations are likely to result 
in beta cell failure, however mutations in this gene are 
not a common cause of isolated autoantibody negative 
diabetes diagnosed in children under 17 years. 
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